HR8005-119

Reported

Stop Pills That Kill Act

119th Congress Introduced Mar 19, 2026

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill expands a reporting req, compliance mandate provision: 4. Comprehensive plan and reduces a reporting req, compliance mandate provision: 5. Report to Congress. It relies on reporting requirements and compliance mandates. The main policy areas are Healthcare.

Who Benefits and How

The available clause analysis does not identify a specific beneficiary group.

Who Bears the Burden and How

No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.

Key Provisions

  • Expands a reporting req, compliance mandate provision: 4. Comprehensive plan.
  • Reduces a reporting req, compliance mandate provision: 5. Report to Congress.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.

At a Glance

What This Bill Does

The bill expands a reporting req, compliance mandate provision: 4. Comprehensive plan and reduces a reporting req, compliance mandate provision: 5. Report to Congress.

Key Policy Areas

Healthcare

Primary Purpose

The bill expands a reporting req, compliance mandate provision: 4. Comprehensive plan and reduces a reporting req, compliance mandate provision: 5. Report to Congress.

Policy Domains

Healthcare

Legislative Progress

Reported
Introduced Committee Passed
Sep 16, 2026

Received in the Senate and Read twice and referred to …

Sep 15, 2026

The title of the measure was amended. Agreed to without …

Sep 15, 2026

Motion to reconsider laid on the table Agreed to without …

Sep 15, 2026

On motion to suspend the rules and pass the bill, …

Sep 15, 2026

Passed/agreed to in House: On motion to suspend the rules …

Sep 15, 2026

DEBATE - The House proceeded with forty minutes of debate …

Sep 15, 2026

Considered under suspension of the rules. (consideration: CR H5674-5676)

Sep 15, 2026

Mr. Guthrie moved to suspend the rules and pass the …

Jul 21, 2026

Ordered to be Reported in the Nature of a Substitute …

Jul 21, 2026

Committee Consideration and Mark-up Session Held

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare
Actor Mappings
"the_administrator"
→ The Administrator identified in the operative section

Key Definitions

Terms defined in this bill

1 term
"counterfeit fentanyl or methamphetamine substance" §H64593A96818D44D89231408465BEE189

a substance that— contains fentanyl, any analogue of fentanyl, or methamphetamine

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology